Global Blood Therapeutics Overview

Global Blood Therapeutics Profit Margin

Profitability ratio analysis for GBT.

Quarterly Profit Margin

-115.26%

↑ 21.24% YoY

As of Jun 2022

Annual Profit Margin (TTM)

-138.97%

↑ 13.98% YoY

Trailing 12 months ending Jun 2022

Average Profit Margin (Comparison Companies)

Profit Margin History

Profit Margin Comparison

Annual Profit Margin Growth Rate (%)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin